Livzon Pharmaceutical Group Inc (000513) — Cash Flow-to-Debt Ratio
Livzon Pharmaceutical Group Inc (000513) has a Cash Flow-to-Debt Ratio of 0.08x as of December 2025, meaning its operating cash flow of CN¥625.70 Million could theoretically repay 0% of its total liabilities (CN¥8.20 Billion) in one year. Explore Livzon Pharmaceutical Group Inc long-term investment intensity to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Livzon Pharmaceutical Group Inc Cash Flow-to-Debt Ratio (1998–2025)
Historical debt coverage capacity for Livzon Pharmaceutical Group Inc across 28 annual periods. Also explore 000513 asset base for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Livzon Pharmaceutical Group Inc (1998–2025)
Year-by-year debt coverage analysis for Livzon Pharmaceutical Group Inc. For market capitalisation and broader financial context, see Livzon Pharmaceutical Group Inc stock valuation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.39x | CN¥3.18 Billion | CN¥8.20 Billion | ▲ +24.3% |
| 2024 | 0.31x | CN¥2.98 Billion | CN¥9.55 Billion | ▼ -1.3% |
| 2023 | 0.32x | CN¥3.25 Billion | CN¥10.28 Billion | ▲ +13.2% |
| 2022 | 0.28x | CN¥2.77 Billion | CN¥9.93 Billion | ▲ +18.3% |
| 2021 | 0.24x | CN¥1.90 Billion | CN¥8.06 Billion | ▼ -24.1% |
| 2020 | 0.31x | CN¥2.16 Billion | CN¥6.95 Billion | ▲ +0.3% |
| 2019 | 0.31x | CN¥1.77 Billion | CN¥5.70 Billion | ▲ +39.1% |
| 2018 | 0.22x | CN¥1.27 Billion | CN¥5.69 Billion | ▼ -21.0% |
| 2017 | 0.28x | CN¥1.32 Billion | CN¥4.66 Billion | ▼ -24.5% |
| 2016 | 0.37x | CN¥1.28 Billion | CN¥3.42 Billion | ▲ +31.6% |
| 2015 | 0.28x | CN¥927.79 Million | CN¥3.27 Billion | ▲ +27.4% |
| 2014 | 0.22x | CN¥717.39 Million | CN¥3.22 Billion | ▲ +50.0% |
| 2013 | 0.15x | CN¥439.99 Million | CN¥2.96 Billion | ▼ -38.6% |
| 2012 | 0.24x | CN¥593.96 Million | CN¥2.45 Billion | ▼ -45.6% |
| 2011 | 0.45x | CN¥708.20 Million | CN¥1.59 Billion | ▼ -28.1% |
| 2010 | 0.62x | CN¥633.30 Million | CN¥1.02 Billion | ▲ +12.5% |
| 2009 | 0.55x | CN¥494.88 Million | CN¥898.92 Million | ▲ +73.7% |
| 2008 | 0.32x | CN¥345.18 Million | CN¥1.09 Billion | ▲ +21.7% |
| 2007 | 0.26x | CN¥248.55 Million | CN¥954.80 Million | ▲ +23.7% |
| 2006 | 0.21x | CN¥226.46 Million | CN¥1.08 Billion | ▲ +20.8% |
| 2005 | 0.17x | CN¥161.07 Million | CN¥925.20 Million | ▼ -1.2% |
| 2004 | 0.18x | CN¥181.46 Million | CN¥1.03 Billion | ▼ -43.9% |
| 2003 | 0.31x | CN¥300.01 Million | CN¥954.70 Million | ▲ +6.9% |
| 2002 | 0.29x | CN¥213.65 Million | CN¥727.05 Million | ▲ +21.1% |
| 2001 | 0.24x | CN¥155.15 Million | CN¥639.37 Million | ▲ +266.2% |
| 2000 | 0.07x | CN¥38.52 Million | CN¥581.24 Million | ▼ -84.3% |
| 1999 | 0.42x | CN¥246.23 Million | CN¥583.95 Million | ▲ +1182.7% |
| 1998 | -0.04x | CN¥-18.21 Million | CN¥467.61 Million | — |